Physiology of the urothelium

Textbook of the Neurogenic Bladder

Volumn , Issue , 2008, Pages 19-39

  Birder, Lori A ^a   de Groat, William C ^a   Apodaca, Gerard ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 76049116341     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (202)

1. Apodaca G. The uroepithelium: not just a passive barrier. Traffic 2004; 5: 1-12.
2. Lewis SA. Everything you wanted to know about the bladder epithelium but were afraid to ask. Am J Physiol 2000; 278: F867-74.
3. Negrete HO, Lavelle JP, Berg J, Lewis SA, Zeidel ML. Permeability properties of the intact mammalian bladder epithelium. Am J Physiol 1996; 271: F886-94.
4. Hu P, Meyers S, Liang F-X et al. Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability. Am J Physiol 2002; 283: F1200-7.
5. Birder LA, de Groat WC. Mechanisms of disease: involvement of the urothelium in bladder dysfunction. Nature Clin Pract Urol 2007; 4: 46-54.
6. Jenkins D, Woolf AS. Uroplakins: new molecular players in the biology of urinary tract malformations. Kidney Int 2007; 71: 195-200.
7. Hicks M. The mammalian urinary bladder: an accommodating organ. Biol Rev 1975; 50: 215-46.
8. Martin BF. Cell replacement and differentiation in transitional epithelium: a histological and autoradiographic study of the guinea-pig bladder and ureter. J Anat 1972; 112: 433-55.
9. Petry G, Amon H. Lichtund elecktronenmikroskopiche Studien über Struktur und Dynamik des Übergangsepithels. Zeitschrift für Zellforschung 1966; 69: 587-612.
10. Acharya P, Beckel J, Wang E et al. Distribution of the tight junction proteins ZO-1, occludin, and claudin-4,-8, and-12 in bladder epithelium. Am J Physiol 2004; 287: F305-18.
11. Hicks RM. The fine structure of the transitional epithelium of rat ureter. J Cell Biol 1965; 26: 25-48.
12. Kachar B, Liang F, Lins U et al. Three-dimensional analysis of the 16 nm urothelial plaque particle: luminal surface exposure, preferential head-to-head interaction, and hinge formation. J Mol Biol 1999; 285: 595-608.
13. Yu J, Manabe M, Sun TT. Identification of an 85-100 kDa glycoprotein as a cell surface marker for an advanced stage of urothelial differentiation: association with the interplaque ('hinge') area. Epithel Cell Biol 1992; 1: 4-12.
14. Liang F, Kachar B, Ding M et al. Urothelial hinge as a highly specialized membrane: detergent-insolubility, urohingin association, and in vitro formation. Differentiation 1999; 65: 59-69.
15. Hicks M, Ketterer B, Warren R. The ultrastructure and chemistry of the luminal plasma membrane of the mammalian urinary bladder: a structure with low permeability to water and ions. Phil Trans Royal Soc London Series B: Biol Sci 1974; 268: 23-38.
16. Porter K, Kenyon K, Badenhausen S. Specializations of the unit membrane. Protoplasma 1967; 63: 262-74.
17. Walz T, Häner M, Wu X-R et al. Towards the molecular architecture of the asymmetric unit membrane of the mammalian urinary bladder epithelium: a closed 'twisted ribbon' structure. J Mol Biol 1995; 248: 887-900.
18. Wu X-R, Lin J-H, Walz T et al. Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. J Biol Chem 1994; 269: 13716-24.
19. Deng F-M, Liang F-X, Tu L et al. Uroplakin IIIb, a urothelial differentiation marker, dimerizes with uroplakin Ib as an early step of urothelial plaque assembly. J Cell Biol 2002; 159: 685-94.
20. Adachi W, Okubo K, Kinoshita S. Human uroplakin Ib in ocular surface epithelium. Invest Ophthalmol Vis Sci 2000; 41: 2900-5.
21. Garcia-España A, Chung P-J, Zhao X et al. Origin of the tetraspanin urolakins and their co-evolution with associated proteins: implications for uroplakin structure and function. Mol Phylo Evol 2006; 41: 355-67.
22. Wu X-R, Medina JJ, Sun TT. Selective interactions of UPIa and UPIb, two members of the transmembrane 4 superfamily, with distinct single transmembrane-domained proteins in differentiated urothelial cells. J Biol Chem 1995; 270: 29752-9.
23. Min G, Wang H, Sun T-T, Kong X-P. Structural basis for tetraspanin functions as revealed by the cryo-EM structure of uroplakin complexes at 6-angstrom resolution. J Cell Biol 2006; 173: 975-83.
24. Parsons CL, Boychuk D, Jones S, Hurst R, Callahan H. Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 1990; 143: 139-42.
25. Parsons CL, Greenspan C, Moore SW, Mulholland SG. Role of surface mucin in primary antibacterial defense of bladder. Urology 1977; 9: 48-52.
26. Van Itallie C, Anderson JM. The molecular physiology of tight junction pores. Physiology 2004; 19: 331-8.
27. Tsukita S, Furuse M. Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 2000; 149: 13-16.
28. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nature Rev Mol Cell Biol 2001; 2: 285-93.
29. González-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Progress Biophys Mol Biol 2003; 81: 1-44.
30. Furuse K, Sasaki H, Fujimoto K, Tsukita S. A single gene product, claudin-1 or-2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 1998; 143: 391-401.
31. Rahner C, Mitic LL, Anderson JM. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 2001; 120: 411-22.
32. Kiuchi-Saishin Y, Gotoh S, Furuse M et al. Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J Am Soc Nephrol 2002; 13: 875-86.
33. Pummi KP, Heape AM, Grénman RA, Peltonen JTK, Peltonen SA. Tight junction proteins ZO-1, occludin, and claudins in developing and adult human perineurium. J Histochem Cytochem 2004; 52: 1037-46.
34. Wilcox ER, Burton QL, Naz S et al. Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell 2001; 104: 165-72.
35. Simon DB, Lu Y, Choate KA et al. Paracellin-1, a renal tight junction protein required for paracellular Mg2-resorption. Science 1999; 285: 103-6.
36. Swisshelm K, Macek R, Kubbies M. Role of claudins in tumorogenesis. Adv Drug Deliv Rev 2005; 57: 919-28.
37. Haynes MD, Martin TA, Jenkins SA et al. Tight junctions and bladder cancer (review). Int J Mol Med 2005; 16: 3-9.
38. McClane BA. The complex interactions between Clostridium perfringens enterotoxin and epithelial tight junctions. Toxicon 2001; 39: 1781-91.
39. McLaughlin J, Padfield PJ, Burt JPH, O'Neill CA. Ochratoxin A increases permeability through tight junctions by removal of specific claudin isoforms. Am J Physiol 2004; 287: C1412-17.
40. Varley C, Hill G, Pellegrin S et al. Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro. Exp Cell Res 2005; 306: 216-29.
41. Apodaca G, Kiss S, Ruiz WG et al. Disruption of bladder epithelium barrier function after spinal cord injury. Am J Physiol 2003; 284: F966-76.
42. Kreft ME, Romih R, Sterle M. Antigenic and ultrastructural markers associated with urothelial cytodifferentiation in primary explant outgrowths of mouse bladder. Cell Biol Int 2002; 26: 63-74.
43. Kreft ME, Sterle M, Veranic P, Jezernik K. Urothelial injuries and the early wound healing response: tight junctions and urothelial cytodifferentiation. Histochem Cell Biol 2005; 123: 529-39.
44. Lavelle J, Meyers S, Ramage R et al. Bladder permeability barrier: recovery from selective injury of surface epithelial cells. Am J Physiol 2002; 283: F242-53.
45. Leppilahti M, Hirvonen J, Tammela TL. Influence of transient overdistension on bladder wall morphology and enzyme histochemistry. Scand J Urol Nephrol 1997; 31: 517-22.
46. Leppilahti M, Kallioinen M, Tammela TL. Duration of increased mucosal permeability of the urinary bladder after acute overdistension: an experimental study in rats. Urol Res 1999; 27: 272-6.
47. Mulvey MA, Lopez-Boado YS, Wilson CL et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 1998; 282: 1494-7.
48. Veranic P, Jezernik K. The response of junctional complexes to induced desquamation in mouse bladder urothelium. Biol Cell 2000; 92: 105-13.
49. Chai TC, Keay S. New theories in interstitial cystitis. Nature Clin Pract Urol 2004; 1: 85-9.
50. Keay SK, Szekely Z, Conrads TP et al. An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc Natl Acad Sci USA 2004; 101: 11803-8.
51. Conrads TP, Tocci GM, Hood BL et al. CKAP64/p63 is a receptor for the Frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients. J Biol Chem 2006; 281: 37836-43.
52. Zhang C-O, Wang J-Y, Koch KR, Keay S. Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from interstiitial cystitis patients. J Urol 2005; 174: 2382-7.
53. Hu P, Deng F-M, Liang F-X et al. Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux. J Cell Biol 2000; 151: 961-71.
54. Kong XT, Deng FM, Hu P et al. Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases. J Cell Biol 2004; 167: 1195-204.
55. Dillon MJ, Goonasekara CD. Reflux nephropathy. J Am Soc Nephrol 1998; 9: 2377-83.
56. Giltay JC, van de Meerakker J, van Amstel HK, de Jong TP. No pathogenic mutations in the uroplakin III gene of 25 patients with primary vesicoureteral reflux. J Urol 2004; 171: 931-2.
57. Kelly H, Ennis S, Yoneda A et al. Uroplakin III is not a major candidate gene for primary vesicoureteral reflux. Eur J Human Gen 2005; 13: 500-2.
58. Jenkins D, Bitner-Blindzicz M, Malcolm S et al. De novo uroplakin IIIa heterozygous mutations cause human renal dysplasia leading to severe kidney failure. J Am Soc Nephrol 2005; 16: 2141-9.
59. Schönfelder E-M, Knüppel T, Tasic V et al. Mutations in uroplakin IIIA are a rare cause of renal hypodysplasia in humans. Am J Kidney Dis 2006; 47: 1004-12.
60. Sakakibara K, Sato K-i, Yoshino K-i et al. Molecular identification and characterization of Xenopus egg uroplakin III, and egg raftassociated transmembrane protein that is tyrosine-phosphorylated upon fertilization. J Biol Chem 2005; 280: 15029-37.
61. Hasan AKMM, Ou Z, Sakakibara K et al. Characterization of Xenopus egg membrane microdomains containing uroplakin Ib/III complex: roles of their molecular interactions for subcellular localization and signal transduction. Genes Cells 2007; 12: 251-67.
62. Hasan AKMM, Sato K-i, Sakakibara K et al. Uroplakin III, a novel Src substrate in Xenopus egg rafts, is a target for sperm protease essential for fertilization. Dev Biol 2005; 286: 483-92.
63. Truschel ST, Wang E, Ruiz WG et al. Stretch-regulated exocytosis/endocytosis in bladder umbrella cells. Mol Biol Cell 2002; 13: 830-46.
64. Wang E, Truschel ST, Apodaca G. Analysis of hydrostatic pressureinduced changes in umbrella cell surface area. Methods 2003; 30: 207-17.
65. Birder LA. More than just a barrier: urothelium as a drug target for urinary bladder pain. Am J Physiol 2005; 289: F489-95.
66. Tempest HV, Dixon AK, Turner WH et al. P2X2 and P2X3 receptor expression in human bladder urothelium and changes in interstitial cystitis. BUJ Int 2004; 93: 1344-8.
67. Birder LA, Barrick SR, Roppolo JR et al. Feline interstitial cystitis results in mechanical hypersensitivity and altered ATP release from bladder urothelium. Am J Physiol 2003; 285: F423-9.
68. Sun Y, Chai TC. Up-regulation of P2X3 receptor during stretch of bladder urothelial cells from patients with interstitial cystitis. J Urol 2004; 171: 448-52.
69. Birder LA, Ruan HZ, Chopra B et al. Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis. Am J Physiol 2004; 287: F1084-91.
70. Sun Y, Keay S, DeDeyne P, Chai TC. Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitital cystitis. J Urol 2001; 166: 1951-6.
71. Min G, Stolz M, Zhou G et al. Localization of uroplakin Ia, the urothelial receptor for bacterial adhesin FimH, on the six inner domains of the 16 nm urothelial plaque particle. J Mol Biol 2002; 317: 697-706.
72. Kau AL, Hunstad DA, Hultgren SJ. Interaction of uropathogenic Escherichia coli with host uroepithelium. Curr Opin Microbiol 2005; 8: 54-9.
73. Anderson GG, Palermo JJ, Schilling JD et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003; 301: 105-7.
74. Gundelfinger ED, Kessels MM, Qualmann B. Temporal and spatial coordination of exocytosis and endocytosis. Nat Rev Mol Cell Biol 2003; 4: 127-39.
75. Hicks R. The function of the Golgi complex in transitional epithelium. J Cell Biol 1966; 30: 623-44.
76. Chang A, Hammond T, Sun T, Zeidel M. Permeability properties of the mammalian bladder apical membrane. Am J Physiol 1994; 267: C1483-92.
77. Lewis S, de Moura J. Incorporation of cytoplasmic vesicles into apical membrane of mammalian urinary bladder epithelium. Nature 1982; 297: 685-8.
78. Amano O, Kataoka S, Yamamoto T. Turnover of asymmetric unit membranes in the transitional epithelial superficial cells of the rat urinary bladder. Anat Rec 1991; 229: 9-15.
79. Sarikas S, Chlapowski F. Effect of ATP inhibitors on the translocation of luminal membrane between cytoplasm and cell surface of transitional epithelial cells during the expansion-contraction cycle of the rat urinary bladder. Cell Tiss Res 1986; 246: 109-17.
80. Sarikas SN, Chlapowski F. The effect of thioglycolate on intermediate filaments and membrane translocation in rat urothelium during the expansion-contraction cycle. Cell Tiss Res 1989; 258: 393-401.
81. Deng F-M, Ding M, Lavker RM, Sun TT. Urothelial function reconsidered: a role in urinary protein secretion. Proc Natl Acad Sci USA 2001; 98: 154-9.
82. Zerial M, McBride H. Rab proteins as membrane organizers, Nature Rev Mol Cell Biol 2001; 2: 107-17.
83. Chen Y, Samaraweera P, Sun TT, Kreibich G, Orlow SJ. Rab27b association with melanosomes: dominant negative mutants disrupt melanosomal movement. J Invest Dermatol 2002; 118: 933-40.
84. Seabra MC, Mules EH, Hume AN. Rab GTPases, intracellular traffic and disease. Trends Mol Med 2002; 8: 23-30.
85. Lewis S, de Moura J. Apical membrane area of rabbit urinary bladder increases by fusion of intracellular vesicle: an electrophysiological study. J Membr Biol 1984; 82: 123-36.
86. Knight GE, Bodin P, de Groat WC, Burnstock G. ATP is released from guinea pig ureter epithelium on distention. Am J Physiol 2002; 282: F281-8.
87. Ferguson DR, Kennedy I, Burton TJ. ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes-a possible sensory mechanism? J Physiol (Lond) 1997; 505(Pt 2): 503-11.
88. Vlaskovska M, Kasakov L, Rong W et al. P2X3 knock-out mice reveal a major sensory role for urothelially released ATP. J Neurosci 2001; 21: 5670-7.
89. Lewis SA, Lewis JR. Kinetics of urothelial ATP release. Am J Physiol 2006; 291: F332-40.
90. Cockayne DA, Hamilton SG, Zhu Q-M et al. Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 2000; 407: 1011-15.
91. Wang ECY, Lee J-M, Ruiz WG et al. ATP and purinergic receptordependent membrane traffic in bladder umbrella cells. J Clin Invest 2005; 115: 2412-22.
92. Birder LA, Nakamura Y, Kiss S et al. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nature Neurosci 2002; 5: 856-60.
93. Elneil S, Skepper JN, Kidd EJ, Williamson JG, Ferguson DR. Distribution of P2X1 and P2X3 receptors in the rat and human urinary bladder. Pharmacology 2001; 63: 120-8.
94. Lee HY, Bardini M, Burnstock G. Distribution of P2X receptors in the urinary bladder and the ureter of the rat. J Urol 2000; 163: 2002-7.
95. Ferguson DR. Urothelial function. BJU Int 1999; 84: 235-42.
96. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz K-N, Linden J. International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53: 527-52.
97. Jacobson KA, Gao Z-G. Adenosine receptors as therapeutic targets. Nature Rev Drug Discov 2006; 5: 247-64.
98. Yu W, Zacharia LC, Jackson EK, Apodaca G. Adenosine receptor expression and function in bladder uroepithelium. Am J Physiol 2006; 291: C254-65.
99. Cheng J, Huang H, Zhang ZT et al. Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth. Cancer Res 2002; 62: 4157-63.
100. Baskin LS, Sutherland RS, Thomson AA, Hayward SW, Cunha GR. Growth factors and receptors in bladder development and obstruction. Lab Invest 1996; 75: 157-66.
101. Bindels EM, van der Kwast TH, Izadifar V, Chopin DK, de Boer WI. Functions of epidermal growth factor-like growth factors during human urothelial reepithelialization in vitro and the role of erbB2. Urol Res 2002; 30: 240-7.
102. Balestreire EM, Apodaca G. Apical EGF receptor signaling: regulation of stretch-dependent exocytosis in bladder umbrella cells. Mol Biol Cell 2007; 18: 1312-23.
103. Daub H, Weiss FU, Wallasch C, Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 1996; 379: 557-60.
104. Birder LA, Kanai AJ, de Groat WC et al. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 2001; 98: 13396-401.
105. Dickson A, Avelino A, Cruz F, Ribeiro-da-Silva A. Peptidergic sensory and parasympathetic fiber sprouting in the mucosa of the rat urinary bladder in a chronic model of cyclophosphamide-induced cystitis. Neuroscience 2006; 141: 1633-47.
106. Jen PY, Dixon JS, Gosling JA. Immunohistochemical localization of neuromarkers and neuropeptides in human fetal and neonatal urinary bladder. Br J Pharmacol 1995; 75: 230-5.
107. Brady CM, Apostolidis AN, Harper M et al. Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment. BJU Int 2004; 93: 770-6.
108. Gillespie JI, Markerink-van Ittersum M, de Vente J. Sensory collaterals, intramural ganglia and motor nerves in the guinea-pig bladder: evidence for intramural neural circuits. Cell Tissue Res 2006; 235: 33-45.
109. Ruan HZ, Birder LA, Xiang Z et al. Expression of P2X and P2Y receptors in the intramural parasympathetic ganglia of the cat urinary bladder. Am J Physiol 2006; 290: F1143-52.
110. Ost D, Roskams T, Van der Aa F, De Ridder D. Topography of the vanilloid receptor in the human bladder: more than just the nerve fibers. J Urol 2002; 168: 293-7.
111. Sui GP, Wu C, Fry CH. Electrical characteristics of suburothelial cells isolated from the human bladder. J Urol 2004; 171: 938-43.
112. Brading AF, McCloskey KD. Mechanisms of disease: specialized interstitial cells of the urothelium: an assessment of current knowledge. Nat Clin Pract Urol 2005; 2: 546-54.
113. Birder LA, Apodaca G, de Groat WC, Kanai AJ. Adrenergic and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder. Am J Physiol 1998; 275: F226-9.
114. Birder LA, Nealen ML, Kiss S et al. Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells. J Neurosci 2002; 22: 8063-70.
115. Burnstock G. Purine-mediated signaling in pain and visceral perception. Trends Pharmacol Sci 2001; 22: 182-8.
116. Chess-Williams R. Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional. Auton Autocoid Pharmacol 2002; 22: 133-45.
117. Chopra B, Barrick SR, Meyers S et al. Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium. J Physiol 2005; 562: 859-71.
118. Beckel JM, Kanai A, Lee SJ, de Groat WC, Birder LA. Expression of functional nicotinic acetylcholine receptors in rat bladder epithelial cells. Am J Physiol 2006; 290: F103-10.
119. Wolf-Johnston AS, Buffington CA, Roppolo JR et al. Increased NGF expression in urinary bladder and sensory neurons from cats with feline interstitial cystitis. Soc Neurosci Abstr 2003; 608: 4.
120. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2005; 84: 579-621.
121. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 2007; 87: 165-217.
122. Birder LA, Wolf-Johnston A, Griffiths D, Resnick NM. Role of urothelial nerve growth factor in human bladder function. Neurourol Urodyn 2007; 26: 405-9.
123. Hanna-Mitchell AT, Beckel JM, Barbadora S et al. Non-neuronal acetylcholine and the urothelium. Life Sci 2007; 80: 2298-302.
124. Cockayne DA, Dunn PM, Zhong Y et al. P2X2 knockout mice and P2X2/P2X4 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP. J Physiol 2005; 567: 621-39.
125. Brady CM, Apostolidis A, Yiangou Y et al. P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin. Eur Urol 2004; 46: 247-53.
126. Apostolidis A, Popat R, Yiangou Y et al. Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 2005; 174: 977-82.
127. Khera M, Somogyi GT, Kiss S, Boone TB, Smith CP. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 2005; 45: 987-93.
128. Smith CP, Vemulkonda VM, Kiss S, Boone TB, Somogyi GT. Enhanced ATP release from bladder urothelium during chronic inflammation: effect of botulinum toxin A. Neurochem Int 2005; 47: 291-7.
129. Tominaga M, Wada M, Masu M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hypersensitivity. Proc Natl Acad Sci 2001; 98: 6951-6.
130. Sculptoreanu A, de Groat WC, Buffington CA, Birder LA. Protein kinase C contributes to abnormal capsaicin responses in DRG neurons from cats with feline interstitial cystitis. Neurosci Lett 2005; 381: 42-6.
131. Hicks GA. TRP channels as therapeutic targets: hot property, or time to cool down? Neurogastroenterol Motil 2006; 18: 590-4.
132. Levine JD, Alessandri-Haber N. TRP channels: targets for the relief of pain. Biochimi Biophys Acta 2007; 1772: 989-1003.
133. Caterina MJ, Schumacher MA, Tominaga M et al. The capsaicin receptor: a heat-activated ion channel in pain pathway. Nature 1997; 89: 816-24.
134. Hwang SW, Cho H, Kwak J et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci 2000; 97: 6155-60.
135. Szallasi A, Blumberg PM. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999; 51: 150-221.
136. Maggi CA. The dual sensory and efferent functions of the capsaicin-sensitive primary sensory neurons in the urinary bladder and urethra. In: Maggi CA, ed. The Autonomic Nervous System, Vol. 3. London: Harwood, 1993: 383-422.
137. Dasgupta P, Fowler CJ. Chillies from antiquity to urology. Br J Urol 1997; 80: 845-52.
138. Szallasi A, Conte B, Goso C, Blumberg PM, Manzini S. Characterization of a peripheral vanilloid (capsaicin) receptor in the rat urinary bladder. Life Sci 1993; 52: PL221-6.
139. Maggi CA, Barbanti G, Santicioli P et al. Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans. J Urol 1989; 142: 150-4.
140. Maggi CA. The dual function of capsaicin-sensitive sensory nerves in the bladder and urethra. Ciba Found Symp 1990; 151: 77-83.
141. Avelino A, Cruz C, Nagy I, Cruz F. Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 2002; 109: 787-97.
142. Silva C, Charrua A, Dinis P, Cruz F. TRPV1 knockout mice do not develop bladder overactivity during acute chemical bladder inflammation. Soc Neurosci Abstr 2004; 288: 16.
143. Szallasi A, Cruz F, Geppetti P. TRPV1: a therapeutic target for novel analgesic drugs? Trends Molec Med 2006; 12: 545-54.
144. Apostolidis A, Brady CM, Yiangou Y et al. Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin. Urology 2005; 65: 400-5.
145. Chancellor MB, de Groat WC. Intravesical capsaicin and resiniferatoxin therapy: spicing up the ways to treat the overactive bladder. J Urol 1999; 162: 3-11.
146. Lazzeri M, Spinelli M, Zanollo A, Turini D. Intravesical vanilloids and neurogenic incontinence: 10 years experience. Urol Int 2004; 72: 145-9.
147. Payne CK, Mosbaugh PG, Forrest JB. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol 2005; 173: 1590-4.
148. Cruz F, Guimaraes M, Silva C et al. Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction. J Urol 1997; 157: 585-9.
149. de Seze M, Wiart L, Joseph PA et al. Capsaicin and neurogenic detrusor hyperreflexia, a double blind placebo controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn 1998; 17: 513-23.
150. Dinis P, Silva J, Ribeiro MJ et al. Bladder C-fiber desensitization induces a long-lasting improvement of BPH-associated storage. LUTS: a pilot study. Eur Urol 2004; 46: 88-93.
151. Fowler CJ, Jewkes D, McDonald WI, Lynn B, de Groat WC. Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 1992; 339: 1239.
152. Geirsson G, Fall M, Sullivan L. Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperreflexia. J Urol 1995; 154: 1825-9.
153. Apostolidis A, Gonzales GE, Fowler CJ. Effect of intravesical resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation. Eur Urol 2006; 50: 1299-305.
154. Mukerji G, Yiangou Y, Agarwal SK, Anand P. Transient receptor potential vanilloid receptor subtype 1 in painful bladder syndrome and its correlation with pain. J Urol 2006; 176: 797-801.
155. Kalsi V, Fowler CJ. Therapy insight: bladder dysfunction associated with multiple sclerosis. Nat Clin Prac Urol 2005; 2: 492-501.
156. Liedtke W. TRPV4 plays an evolutionary conserved role in the transduction of osmotic and mechanical stimuli in live animals. Pflugers Arch 2005; 451: 176-80.
157. Gevaert T, Vriens J, Everaerts W, Nilius B, De Ridder D. TRPV4 is localized on urothelium: does it play a role in afferent bladder signaling? Eur Urol Suppl 2007; 6: 38.
158. Barrick S, Lee H, Caterina M et al. Expression and function of TRPV4 in urinary bladder urothelium. Soc Neurosci Abstr 2003; 608: 6.
159. Alessandri-Haber N, Dina OA, Joseph EK, Reichling D, Levine JD. A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators. J Neurosci 2006; 26: 3864-74.
160. Cheng C-L, Chai CY, de Groat WC. Detrusor-sphincter dyssynergia induced by cold stimulation of the urinary bladder of rats. Am J Physiol 1997; 41: R1271-82.
161. Wein AJ. Neuromuscular dysfunction of the lower urinary tract. In: Walsh PC, Retik AB, Stamey TA, Vaughn ED, eds. Campbell's Urology. Saunders, Philadelphia, 1992: 573-642.
162. Chai TC, Gray J, Steers W. The incidence of a positive ice water test in bladder outlet obstructed patients: evidence for bladder neural plasticity. J Urol 1998; 160: 34-8.
163. Gotoh M, Yoshikawa Y, Kondo AS et al. Positive bladder cooling reflex in patients with bladder outlet obstruction due to benign prostatic hyperplasia. World J Urol 1999; 17: 126-30.
164. Hirayama A, Fujimoto K, Matumoto Y, Ozono S, Hirao Y. Positive response to ice water test associated with high-grade bladder outlet obstruction in patients with benign prostatic hyperplasia. Urology 2003; 62: 909-13.
165. Peier AM, Moqrich A, Hergarden AC et al. A TRP channel that senses cold stimuli and menthol. Cell 2002; 108: 705-15.
166. Jiang CH, Mazieres L, Lindstrom S. Cold and menthol-sensitive C afferents of cat urinary bladder. J Physiol 2002; 543: 211-20.
167. Geirsson G, Lindstrom S, Fall M. The bladder cooling reflex and the use of cooling as stimulus to the lower urinary tract. J Urol 1999; 162: 1890-6.
168. Stein RJ, Santos S, Nagatomi J et al. Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J Urol 2004; 172: 1175-8.
169. Barrick S, Chopra B, Caterina M et al. Expression and function of the cold channels in urinary bladder urothelium: TRPM8 and TRPA1. 24th Annual American Pain Society Meeting, Banff, Canada, 2005.
170. Andrade EL, Ferreira J, Andre E, Calixto J. Contractile mechanisms coupled to TRPA1 receptor activation in rat urinary bladder. Biochem Pharmacol 2006; 72: 104-14.
171. Hawthorn MH, Chapple CR, Cock M, Chess-Williams R. Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro. Br J Pharmacol 2000; 129: 416-9.
172. Templeman L, Chapple CR. Chess-Williams R. Urothelium derived inhibitory factor and cross-talk among receptors in the trigone of the bladder of the pig. J Urol 202; 167: 742-5.
173. De Groat WC. The urothelium in overactive bladder: passive bystander or active participant? Urology 2004; 64: 7-11.
174. Beckel JM, Barrick SR, Keast JR et al. Expression and function of urothelial muscarinic receptors and interactions with bladder nerves. Soc Neurosci Abstr 2004; 846: 23.
175. Birder LA. Role of the bladder epithelium in urinary bladder dysfunction after spinal cord injury. In: Weaver LC, Polosa C, eds. Autonomic Dysfunction after Spinal Cord Injury: The Problems and Underlying Mechanisms. Progress in Brain Research. Amsterdam: Holland: Elsevier, 2004.
176. Tong YC, Cheng JT, Hsu CT. Alterations of M(2)-muscarinic receptor protein and mRNA expression in the urothelium and muscle layer of the streptozotocin-induced diabetic rat urinary bladder. Neurosci Lett 2006; 406: 216-21.
177. Mansfield KJ, Liu L, Mitchelson FJ et al. Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol 2005; 144: 1089-99.
178. Braverman AS, Lebed B, Linder M, Ruggieri MR. M2 mediated contractions of human bladder from organ donors is associated with an increase in urothelial muscarinic receptors. Neurourol Urodyn 2007; 26: 63-70.
179. Yoshida M, Inadome A, Maeda Y et al. Non-neuronal cholinergic system in human bladder urothelium. Urology 2006; 67: 425-30.
180. Lips KS, Wunsch J, Zarghooni S et al. Acetylcholine and molecular components of its synthesis and release machinery in the urothelium. Eur Urol 2007; 51: 1047-53.
181. Kim YT, Yoshimura N, Masuda H, De Miguel F, Chancellor MB. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder afferent pathways. Urology 2004; 65: 238-42.
182. de Groat WC. Integrative control of the lower urinary tract: preclinical perspective. Br J Pharmacol 2006; 147: S25-40.
183. Cheng CL, Liu JC, Chang SY, Ma CP, de Groat WC. Effect of capsaicin on the micturition reflex in normal and chronic spinal cordinjured cats. Am J Physiol 1999; 277: R786-94.
184. Yoshida M, Miyamae K, Iwashita H, Otani M, Inadome A. Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology 2004; 63: 17-23.
185. Proskocil BJ, Sekhon SS, Jia Y et al. Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells. Endocrinol 2004; 145: 2498-506.
186. Tiwari A, Naruganahalli KS. Current and emerging investigational medical therapies for the treatment of overactive bladder. Expert Opin Investig Drugs 2006; 15: 1017-37.
187. Chancellor MB. Urgency, botulinum toxin and how botulinum toxin can help urgency. J Urol 2005; 174: 818.
188. Toft BR, Nordling J. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review. Current Opin Urol 2006; 16: 268-72.
189. Atiemo H, Wynes J, Chuo J et al. Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model. Urology 2005; 65: 622-6.
190. Toh KL, Ng CK. Urodynamic studies in the evaluation of young men presenting with lower urinary tract symptoms. Int J Urol 2006; 13: 520-3.
191. Yassin A, Saad F, Hoesl CE et al. Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS-implications for clinical practice. Andrologia 2006; 38: 1-12.
192. Ishihama H, Momota Y, Yanase H et al. Activation of alpha1D adrenergic receptors in the rat urothelium facilitates the micturition reflex. J Urol 2006; 175: 358-64.
193. Andersson KE, Persson K. Nitric oxide synthase and the lower urinary tract: possible implications for physiology and pathophysiology. Scand J Urol Nephrol Suppl 1995; 175: 43-53.
194. Pandita RK, Mizusawa H, Andersson KE. Intravesical oxyhemoglobin initiates bladder overactivity in conscious, normal rats. J Urol 2000; 164: 545-50.
195. de Groat WC, Kruse MN, Vizzard MA et al. Modification of urinary bladder function after spinal cord injury. Adv Neurol 1997; 72: 347-64.
196. Vizzard MA. Neurochemical plasticity and the role of neurotrophic factors in the bladder reflex pathways after spinal cord injury. Prog Br Res 2006; 152: 97-115.
197. Birder LA, Wolf-Johnston A, Buffington CA et al. Altered inducible nitric oxide synthase expression and nitric oxide production in the bladder of cats with feline interstitial cystitis. J Urol 2005; 172: 625-9.
198. Kolios G, Valata V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004; 113: 427-37.
199. Yoshimura N, Seki S, de Groat WC. Nitric oxide modulates Ca2-channels in dorsal root ganglion neurons innervating rat urinary bladder. J Neurophysiol 2001; 86: 304-11.
200. Ozawa H, Chancellor MB, Jung SY et al. Effect of intravesical nitric oxide therapy on cyclophosphamide-induced cystitis, J Urol 1999; 162: 2211-16.
201. Korkmaz A, Oter S, Sadir S et al. Peroxynitrite may be involved in bladder damage caused by cyclophosphamide in rats. J Urol 2005; 173: 1793-6.
202. Hosseini A, Ehren I, Wiklund NP. Nitric oxide as objective marker for evaluation of treatment response in patients with classic interstitial cystitis. J Urol 2004; 172: 2261-5.